Health Care/Hospital

Kemwell BioPharma Drives Quality Excellence with Veeva Vault QMS

Pioneering biologics CDMO rapidly adopts Veeva Vault QMS to advance development and manufacturing operations BANGALORE, India, April 2, 2024 /PRNewswire/ -- Veeva Systems  (NYSE: VEEV) today announced that Kemwell BioPharma, India's largest biologics contract developmen...

2024-04-02 10:30 2130

InsureMO partners with MoneyHero Group to create the premiere digital insurance aggregation and comparison platform in Greater Southeast Asia

SINGAPORE, April 2, 2024 /PRNewswire/ -- InsureMO is thrilled to announce its strategic partnership with MoneyHero Limited (NASDAQ: MNY) to create the premiere digital insurance aggregation and comparison platform inGreater Southeast Asia. InsureMO's cutting-edge middleware platform has been s...

2024-04-02 10:00 3462

23WELL, THE health supplement brand on the watch

LOS ANGELES, April 1, 2024 /PRNewswire/ -- Just earlier last month, the highly anticipated Natural Products Expo West 2024 concluded successfully inAnaheim, CA. As one of the world's largest leading health and nutrition exhibition, it hosted more than 65,000 registered attendees and 3,000+ exhibi...

2024-04-02 09:07 1968

Oncoclínicas&Co has revenues of R$6 billion and profit of R$313 million in 2023

Increase in the number of patients treated and gains in operational efficiency explain record results SÃO PAULO, April 2, 2024 /PRNewswire/ -- Oncoclínicas&Co (B3: ONCO3) – the largest group dedicated to cancer treatment inLatin America – reported a 35.1% growth in its gross revenue in 2023, tot...

2024-04-02 00:38 2155

ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones

TOKYO, April 1, 2024 /PRNewswire/ -- ThinkCyte today announced the publication of apaper in the March issue of Cell Reports Methods on a new method for high-throughput drug discovery. Together with a joint research group including investigators at theUniversity of Tokyo and the University of Brit...

2024-04-01 21:00 2127

Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification

- Lunit's AACR 2024 presentations to spotlight HER2 mutation insights and CNTN4's role in immunotherapy success, pioneering next-gen personalized treatment approaches, supported by the AI-powered Lunit SCOPE suite SEOUL, South Korea, April 1, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading...

2024-04-01 21:00 1995

Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development

PROVIDENCE, R.I., April 1, 2024 /PRNewswire/ -- In the pursuit of developing novel biologic entities, scientists harnessing the power of AI and generative biology depend on computational tools for predicting and managing immunogenicity risk – a critical characterization step in the candidate dev...

2024-04-01 20:00 2497

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

HONG KONG, April 1, 2024 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today announced unaudited financial results for the fourth quarter and full year endedDecember 31, 2023, along with recent business up...

2024-04-01 19:30 3025

Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO

~Hidemasa's appointment bolsters Aculys' position as a leader in the field of CNS inJapan and Asia~ TOKYO, April 1, 2024 /PRNewswire/ -- Aculys Pharma, Inc. ("Aculys"), a clinical-stage biopharmaceutical company focused on commercializing innovative treatments for neurological conditions, today ...

2024-04-01 14:30 1601

Sixth Appearance at Boao Forum for Asia: Yili Demonstrates Innovative Vigor to the World

BOAO, China, April 1, 2024 /PRNewswire/ -- From March 26th to March 29th, the Boao Forum forAsia is once again underway, with Yili Group being invited for the sixth time to participate in this grand event, showcasing its innovative strength grounded in quality.

2024-04-01 14:06 1964

Elovi Renames to Morinaga Nutritional Foods Vietnam, Fusing Expertise and Technology 'For Better Wellness' in Vietnam

HANOI, Vietnam, April 1, 2024 /PRNewswire/ -- Elovi, a group company of Morinaga Milk Industry (Japan), announces a significant transformation. In a strategic move to further enhance its mission and align with global standards of excellence, Elovi is proud to unveil its new identity asMorinaga Nu...

2024-04-01 12:00 2341

2024 Kaohsiung Smart City Summit & Expo Showcases Latest Digital and Net-Zero Transformation Technologies

KAOHSIUNG, April 1, 2024 /PRNewswire/ -- The 2024 Kaohsiung Smart City Summit & Expo(KSCSE), held at the Kaohsiung Exhibition Center, concluded perfectly. Over the course of the 3-day exhibition, it attracted more than 40,000 visitors. There were a total of 150 exhibitors, 550 booths, and 6 main ...

2024-04-01 10:57 830

IMM CAREHUB - REDEFINING HEALTHY AGEING AND GERIATRIC REHABILITATION IN ASIA

KUALA LUMPUR, Malaysia, April 1, 2024 /PRNewswire/ --IMM Carehub, a pioneer in preventive care, healthy ageing, and geriatric rehabilitation, continues to make waves in the healthcare industry. AsMalaysia's First Lifestyle Rehab Centre for Seniors, IMM Carehub stands as a beacon of innovation and...

2024-04-01 09:00 1639

OFFICIAL LAUNCH OF THE NATIONAL UNIVERSITY SPINE INSTITUTE (NUSI): LEADING SPINE CARE INTO THE FUTURE

Public symposium by NUSI marks the end of a series of spine-related events that provide doctors with platform for professional development and networking SINGAPORE, March 30, 2024 /PRNewswire/ -- The National University Spine Institute (NUSI) is a new dedicated specialist spine institute under th...

2024-03-30 11:00 2867

CAIR-HK AI & Robotics Forum for Healthcare: Spotlight Interdisciplinary Integration of AI and Medicine

HONG KONG, March 29, 2024 /PRNewswire/ -- In this data-driven era, artificial intelligence and robotics technologies are rapidly reshaping people's lifestyles, with their profound impact in the field of medicine and healthcare becoming increasingly evident. From image-assisted diagnosis to intell...

2024-03-29 23:00 3556

Baird Medical Granted New Class III Certificate by China's NMPA for Ceramic Thyroid Ablation Needle

FRISCO, Texas, March 29, 2024 /PRNewswire/ -- Baird Medical Devices, Inc. ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina and the United States, today announced it has been granted a new Class III certificate by the National ...

2024-03-29 21:37 2583

LISCure Biosciences receives U.S. FDA Fast Track designation for LB-P8 for the treatment of primary sclerosing cholangitis (PSC)

* Phase 2 study is underway and LB-P8 is the only live biotherapeutic product currently reported to be in clinical development for the treatment of PSC * FDA's Fast Track designation for LB-P8 underlines the urgent need for treatment options to fulfill the unmet medical needs of people affecte...

2024-03-29 21:00 2677

Aohua receives Endoscopy Award at Healthcare Asia Medtech Awards 2024

SINGAPORE, March 29, 2024 /PRNewswire/ -- At the most recent Healthcare Asia Medtech Awards 2024, Aohua Endoscopy, a medical equipment manufacturer, won the Endoscopy Product Innovation Award for creating the Aohua4K AQ-300 video endoscopy system, which provides a better endoscopic diagnosis and ...

2024-03-29 21:00 3801

73% CNS ORR! FDA Granted ODD to Utidelone Injectable (UTD1) from Biostar Pharma for the Treatment of Breast Cancer Brain Metastasis

SAN FRANCISCO, March 29, 2024 /PRNewswire/ -- Biostar Pharma, Inc., the U.S. subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic biology driven biopharma company focusing on the development and commercialization of innovative oncology drugs, announced today that their cor...

2024-03-29 20:40 2186

Alebund's Innovative Investigational Drug AP303 Receives FDA Orphan Drug Designation (ODD) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

SHANGHAI, March 29, 2024 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic conditions, announced today that th...

2024-03-29 20:00 1769
1 ... 107108109110111112113 ... 848

Week's Top Stories